The Invesco Biotechnology & Genome ETF (PBE) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. What ...

The top 10 holdings account for about 45.06% of total assets under management. So far this year, PBE has gained about 1.19%, and is up about 18.40% in the last one year (as of 11/20/2024).